Individualizing liver transplant immunotolerance and Tregs
Biomarker for tolerance – who can have immunosuppression withdrawn?
Gene editing for graft function improvement
Regional immunoregulation on liver graft injury and disease recurrence
Impact of donor steatosis on short and long term outcome post LT – Western experience
Impact of donor steatosis on short and long term outcome post LT – Eastern experience
De-novo fatty liver post LT: Is this a new disease?
NASH and sarcopenia in listed LT patients
NASH recurrence post LT: targets treatment for prevention
Perioperative coagulation: Pro and Con
AKI prediction scores in DBD and DCD
Cirrhotic Cardiomyopathy
The brain and liver
When the lung contraindicates a liver transplant
Pre transplant evaluation and management of a patient with diffuse PVT on the waiting list: staging, medical management, anticoagulation
Converting untransplantable patients with chronic obliterative PVT and cavernoma to transplantability using trans-splenic portal vein recanalization TIPS
Outcomes of LT in a recipient with diffuse PVT: True survival benefit and implications for organ allocation
DEBATE: Surgical options in patients with diffuse (Grade 4 Yerdel) PVT: i) Liver transplant with inflow from vessels of all types and sizes is possible ii) Multi-Visceral Transplant is the best option iii) Discussion
DEBATE: Surgical options in patients with diffuse (Grade 4 Yerdel) PVT: i) Liver transplant with inflow from vessels of all types and sizes is possible ii) Multi-Visceral Transplant is the best option iii) Discussion
Expanding Indications for pediatric LT – How to identify the need?
Saving livers whilst saving lives in advanced hepatoblastoma: extended resection vs liver transplantation (Case Presenter + Discussant)
The agelessness of frailty in liver transplantation
Expanding the donor pool
The new development of pediatric LDLT in mainland China
NASH – potential perioperative problems
Histological findings in late paediatric post-transplant biopsies: what the pathologist sees that we don’t see
Subclinical chronic graft injury in very stable pediatric liver transplant recipients: What the clinician has to deal with?
The challenges with TOO LITTLE immunosuppression: Non-adherence – enough of the talk – what can we actually do about this?
The challenges with TOO MUCH immunosuppression: Extra-hepatic diseases in liver transplanted children and adolescents – cardiovascular, PTLD, renal
Transition from pediatric to adult care after pediatric liver transplantation: What do adult care teams need from the pediatric teams?
An evidence based review of TEG/ROTEM guided coagulation management
Treatment and prophylaxis of pre- and postoperative thromboses
Transplanting a DCD-liver: perioperative challenges
Extracorporeal liver support in ALF and ACLF
Transplant Center Performance is Adequately Reflected in 1yr Graft and Patient Survival a) Yes b) No
Transplant Center Performance is Adequately Reflected in 1yr Graft and Patient Survival a) Yes b) No
DCD should only go to “healthy” recipients: a) Yes b) No
DCD should only go to “healthy” recipients: a) Yes b) No
Simultaneous liver and kidney transplant vs. sequential kidney after liver transplant in decompensated CLD with AKI: Which is more feasible and safe? a) SLKT b) Sequential transplant
Beyond patient and graft survival: How do we know that we are any good?
ERAS for Liver Transplantation
Re-weight the value of liver transplantation – the recipient benefit
Re-weight the value of liver transplantation – the donor benefit
The role of multidisciplinary care
Smart matching: applying artificial neural networks in liver transplantation
Curative ex vivo hepatocyte – directed gene editing: how far away from reality?
Ex situ machine perfusion as a tool to recondition steatotic donor livers
Precision transplant pathology
Molecular scissors: Gene editing applied to liver transplantation – new approaches to modeling liver diseases
Organ allocation for patients with cancer
Response to LRT and other surrogates of tumor biology: importance for transplant outcomes in HCC
Time to think of liver transplantation for intrahepatic cholangiocarcinoma
Ex vivo liver resection and autotransplantation for end-stage hepatic alveolar echinococcosis
The new pipeline of drugs in transplant oncology
Solving an imbalanced liver transplantation problem: AI and efficient decision-support models for liver allocation
Pitfalls of current allocation systems in US
Pitfalls of current allocation systems in Europe
Current organ allocation system in mainland of China
Shifting allocation from living donation to deceased donation
Sepsis in the post-transplant patient
Acute but different – key management decisions in ACLF vs. ALF
Hepatopulmonary syndrome – path to successful transplantation
Frailty in ICU: implications for transplant candidacy
Surgical planning for living donor liver transplant using 4D flow MRI, computational fluid dynamics and in vitro experiments
Current State-of-the-Art MRI for comprehensive evaluation of otential living liver donors
3-D visualized and VR technology in liver surgery
Liver histopathology: from normal to diseased conditions requiring liver transplantation
HCC diagnosis in pretransplant and explanation liver: what we shouldn’t miss
Pathology of hepatic vascular disorders and their relevance to liver transplantation
